Tatva Chintan Pharma Chem Limited (TATVA) - Total Liabilities

Latest as of September 2025: Rs1.53 Billion INR ≈ $16.58 Million USD

Based on the latest financial reports, Tatva Chintan Pharma Chem Limited (TATVA) has total liabilities worth Rs1.53 Billion INR (≈ $16.58 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Tatva Chintan Pharma Chem Limited - Total Liabilities Trend (2018–2025)

This chart illustrates how Tatva Chintan Pharma Chem Limited's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Tatva Chintan Pharma Chem Limited to evaluate short-term liquidity relative to the company's equity base.

Tatva Chintan Pharma Chem Limited Competitors by Total Liabilities

The table below lists competitors of Tatva Chintan Pharma Chem Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Funko Inc NASDAQ:FNKO	USA	$456.73 Million
T3EX Global Holdings Corp TW:2636	Taiwan	NT$12.71 Billion
Ritek Corp TW:2349	Taiwan	NT$8.30 Billion
Leysen Jewellery Inc SHG:603900	China	CN¥391.35 Million
E Split Corp Class A TO:ENS	Canada	CA$231.30 Million
Iljin HySolus Co Ltd KO:271940	Korea	₩35.46 Billion
Hubei Guangji Pharmaceutical Co Ltd SHE:000952	China	CN¥1.70 Billion
Arvind SmartSpaces Limited NSE:ARVSMART	India	Rs19.07 Billion

Liability Composition Analysis (2018–2025)

This chart breaks down Tatva Chintan Pharma Chem Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Tatva Chintan Pharma Chem Limited.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.95	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.20	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.17	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tatva Chintan Pharma Chem Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tatva Chintan Pharma Chem Limited (2018–2025)

The table below shows the annual total liabilities of Tatva Chintan Pharma Chem Limited from 2018 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs974.25 Million ≈ $10.54 Million	+19.34%
2024-03-31	Rs816.36 Million ≈ $8.83 Million	-66.20%
2023-03-31	Rs2.42 Billion ≈ $26.12 Million	+30.40%
2022-03-31	Rs1.85 Billion ≈ $20.03 Million	+24.44%
2021-03-31	Rs1.49 Billion ≈ $16.10 Million	+13.41%
2020-03-31	Rs1.31 Billion ≈ $14.19 Million	+21.74%
2019-03-31	Rs1.08 Billion ≈ $11.66 Million	+26.46%
2018-03-31	Rs852.48 Million ≈ $9.22 Million	--

About Tatva Chintan Pharma Chem Limited

NSE:TATVA India Specialty Chemicals

Market Cap

$302.61 Million

Rs27.98 Billion INR

Market Cap Rank

#14869 Global

#743 in India

Share Price

Rs1196.20

Change (1 day)

+0.23%

52-Week Range

Rs907.70 - Rs1588.70

All Time High

Rs2866.25